GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Ventures Inc (XCNQ:J) » Definitions » EV-to-EBITDA

Lotus Ventures (XCNQ:J) EV-to-EBITDA : -3.32 (As of May. 16, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Ventures EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lotus Ventures's enterprise value is C$3.29 Mil. Lotus Ventures's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 was C$-0.99 Mil. Therefore, Lotus Ventures's EV-to-EBITDA for today is -3.32.

The historical rank and industry rank for Lotus Ventures's EV-to-EBITDA or its related term are showing as below:

XCNQ:J' s EV-to-EBITDA Range Over the Past 10 Years
Min: -77.36   Med: 5.12   Max: 21.31
Current: -3.32

During the past 12 years, the highest EV-to-EBITDA of Lotus Ventures was 21.31. The lowest was -77.36. And the median was 5.12.

XCNQ:J's EV-to-EBITDA is ranked worse than
100% of 707 companies
in the Drug Manufacturers industry
Industry Median: 14.79 vs XCNQ:J: -3.32

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Lotus Ventures's stock price is C$0.01. Lotus Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was C$-0.021. Therefore, Lotus Ventures's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Lotus Ventures EV-to-EBITDA Historical Data

The historical data trend for Lotus Ventures's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Ventures EV-to-EBITDA Chart

Lotus Ventures Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.76 -5.40 4.24 10.12 -1.15

Lotus Ventures Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.15 -1.15 -1.36 -1.22 -5.59

Competitive Comparison of Lotus Ventures's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Ventures's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Ventures's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Ventures's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lotus Ventures's EV-to-EBITDA falls into.



Lotus Ventures EV-to-EBITDA Calculation

Lotus Ventures's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3.289/-0.991
=-3.32

Lotus Ventures's current Enterprise Value is C$3.29 Mil.
Lotus Ventures's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Ventures  (XCNQ:J) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lotus Ventures's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.01/-0.021
=At Loss

Lotus Ventures's share price for today is C$0.01.
Lotus Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Lotus Ventures EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lotus Ventures's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Ventures (XCNQ:J) Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 1010, Vancouver, BC, CAN, V6E 2Y3
Lotus Ventures Inc is a licensed cannabis producer that serves customers in Canada. The company created a purpose-built facility with proprietary standard operating procedures to reliably produce rare and high-quality strains of cannabis for consumers looking for a consistent experience.